Try our new research platform with insights from 80,000+ expert users

Kaspersky Anti-Targeted Attack Platform vs Morphisec comparison

Sponsored
 

Comparison Buyer's Guide

Executive SummaryUpdated on Sep 9, 2024

Review summaries and opinions

We asked business professionals to review the solutions they use. Here are some excerpts of what they said:
 

Categories and Ranking

Cortex XDR by Palo Alto Net...
Sponsored
Ranking in Endpoint Detection and Response (EDR)
7th
Average Rating
8.4
Reviews Sentiment
6.8
Number of Reviews
108
Ranking in other categories
Endpoint Protection Platform (EPP) (5th), Extended Detection and Response (XDR) (6th), Ransomware Protection (2nd), AI-Powered Cybersecurity Platforms (2nd)
Kaspersky Anti-Targeted Att...
Ranking in Endpoint Detection and Response (EDR)
52nd
Average Rating
6.6
Reviews Sentiment
6.1
Number of Reviews
6
Ranking in other categories
No ranking in other categories
Morphisec
Ranking in Endpoint Detection and Response (EDR)
61st
Average Rating
9.2
Reviews Sentiment
7.4
Number of Reviews
21
Ranking in other categories
Vulnerability Management (57th), Endpoint Protection Platform (EPP) (49th), Advanced Threat Protection (ATP) (31st), Cloud Workload Protection Platforms (CWPP) (34th), Threat Deception Platforms (21st)
 

Mindshare comparison

As of March 2026, in the Endpoint Detection and Response (EDR) category, the mindshare of Cortex XDR by Palo Alto Networks is 3.4%, down from 4.0% compared to the previous year. The mindshare of Kaspersky Anti-Targeted Attack Platform is 0.7%, up from 0.1% compared to the previous year. The mindshare of Morphisec is 0.7%, up from 0.5% compared to the previous year. It is calculated based on PeerSpot user engagement data.
Endpoint Detection and Response (EDR) Mindshare Distribution
ProductMindshare (%)
Cortex XDR by Palo Alto Networks3.4%
Kaspersky Anti-Targeted Attack Platform0.7%
Morphisec0.7%
Other95.2%
Endpoint Detection and Response (EDR)
 

Featured Reviews

ABHISHEK_SINGH - PeerSpot reviewer
Senior Process Expert at A.P. Moller - Maersk
Gained full visibility and streamlined threat detection through behavior-based insights and AI integration
Initially, we got to have a lot of false positives when we onboarded, but nowadays it's quite smooth. We have fine-tuned our security policies and allowed different levels of policies to get rid of those false positives. Currently, we are getting a fairly good amount of incidents that are not false positives or benign, but actionable items. The process is streamlined. In the initial days, the operations used to get involved in a lot of benign and other activities, but now the process is streamlined. We are leveraging the auto-detection and remediation plans. The operations teams are now more involved in other business roles as well, not just looking into the logs and fetching out what's happening there. They have fixed a lot of things. Initially, they didn't have IAC code drift detection, cloud posture management, or security posture management, but they have those now. They purchased different vendors and did a merger with that. They have now Prisma Cloud that gets integrated and now they are working with Cortex Cloud. Everything that was negative has now been addressed, and the product altogether looks to be in a very better and mature shape now. Currently, it's more or less detecting the workloads with AI-based best practices. Since most organizations are consuming AI agents and other things, we are looking forward to seeing what other feature enhancements Palo Alto can support in that.
FarkhundAbbas - PeerSpot reviewer
Security Engineer at adcb
The tool provides excellent sandboxing and email security features, but the backup and recovery features are not good
If my primary solution is down, no backup solution is available to restore it. It is one of the biggest weaknesses of the platform. If I need to update the solution, there is no option to pick the events and the logs from it and deploy it in another solution. The backup and recovery features of the product are not good. I need backup. If the tool is down for some time, I cannot get the logs at that particular time.
Rick Schibler - PeerSpot reviewer
VP of Information Technology at Kentucky Trailer
Offers in-memory protection at a lower price than competitors
Morphisec's in-memory protection is probably the most valuable feature because it stops malicious activity from occurring. If something tries to install or act as a sleeper agent, Morphisec will detect and stop it. Morphisec's Moving Target Defense is critical to hardening our attack surface. If it detects something, it indicates whether it's valid. That means you've got a breach requiring investigation. It detects anomalies but doesn't necessarily point to what caused them. You still need to do that work. The solution is reasonably easy to administer. They made some changes last year, adding a cloud-based monitoring solution that makes deploying and monitoring our endpoints easy.

Quotes from Members

We asked business professionals to review the solutions they use. Here are some excerpts of what they said:
 

Pros

"The initial setup isn't too bad."
"This software helps us understand any issues that may arise when someone is not at work."
"The most valuable feature of Cortex XDR by Palo Alto Networks is its machine-learning capabilities. Additionally, there is full integration with other solutions."
"The behavior-based detection feature is valuable."
"The most valuable for us is the correlation feature."
"Cortex Xnor's playbooks predefine the workflow of the automation, such as response processes, alert triggering, and enriching the context, collecting relevant indicators such as hashes, IP addresses, or domains efficiently and can detect and block malicious attacks with firewalls."
"The product has an intuitive dashboard."
"It blocks malicious files, prevents attacks, and doesn't require many updates because it is a very light application."
"Kaspersky Anti-Targeted Attack Platform is stable and runs all the time."
"The product's deployment phase is easy."
"The email security feature is really good."
"I feel the anti-ransomware update is one of the tool's valuable features."
"The most valuable use is detailing metadata collection from the endpoint and network."
"The solution is very easy to use. Its interface is very simple, and you can build IOC's indicators. You can use your rules to detect these attacks because you can leverage threat intelligence. Y"
"The simplicity of the solution, how easy it is to deploy and how small it is when deployed as an agent on a device, is probably the biggest aspect, given what it can do."
"The biggest feature is that it hides everything from your operating system that's running in-memory from anything to try to run against it. That's the most unique thing that's on the market. There's nothing else out there that's quite like that. That's a big selling point and why we went with it. It does exactly what the design does. If you can't find it, you can't execute against it."
"Morphisec is a straightforward solution that is efficient and very stable."
"We have seen it successfully block attacks that a traditional antivirus did not pick up."
"Morphisec has absolutely helped save money on our security stack. The ransomware at the end of the day can cost organizations millions upon millions of dollars. Investing in tools like Morphisec is a great reduction in that cost. If I can spend $10,000 in a year to protect assets that could be ransomed for $20,000,000, that's definitely a bet that one should pursue. Morphisec absolutely it's worth the investment."
"It also provides full visibility into security events from Microsoft Defender and Morphisec in one dashboard. We've always had that capability with Morphisec. The more recent version appears to do that even a little bit more natively and it's given us visibility that we didn't have otherwise."
"Morphisec makes use of deterministic attack prevention that doesn’t require investigation of security alerts. It changes the memory locations of where certain applications run. If you think of Excel, opening a PDF, running an Excel macro, or opening a webpage and clicking on a link, all of those actions run in a certain area of memory. Morphisec changes the memory locations of where those run."
"I really like the integration with Microsoft Defender. In addition to having third-party endpoint protection, we're also enabling Defender... I like the reporting that we get from Defender, when it comes in. I like that it's one console showing both Morphisec and Defender where it provides me with full visibility into security events from Defender and Morphisec."
 

Cons

"The complexity and confusion regarding product variants, such as XDR, Forexiant, and Forexon, must be addressed."
"It would be good to have a better way to search for a file within the UI."
"Cortex XDR should have a lightweight agent, and the agent size should not be heavy."
"Although I would say this product is highly-rated, it could probably do more because nothing does everything that you want."
"Cortex XDR by Palo Alto Networks is a very good product, but financially, it is very expensive, so the company should look into that area."
"When it comes to core analysis, and security analysis, Cortex needs to provide more information."
"While using Cortex, I noticed some aspects that could be improved, such as increasing the synchronization speed between XDR and Xnor."
"The product's pricing could be better."
"Kaspersky Anti-Targeted Attack Platform is not a good product. We had problems with endpoints and the solution did not detect it. We didn't get any alerts about the attack."
"In some of the places I have come across, even though they use Kaspersky, the ransomware enters their system."
"I think the tool is still not really good enough for integration compared to other products."
"The blind spot or gap in the platform is network analysis functionality."
"The backup and recovery features of the product are not good."
"The solution lacks cloud integrations."
"We sometimes have to depend on the support team to know what action we should take. If the solution for an alert can be built into the report that we are getting, it will save time, and the interaction with support would be less. At times, corrective action is required, but at times, we don't need to take any action. It would be good if we get to know in the report that a particular infection doesn't require any action. It will save us time and effort."
"If anything, tech support might be their weakest link. The process of getting someone involved sometimes takes a little time. It seems to me that they should have all the data they need to let me know whether an alert is legitimate or not, but they tend to need a lot of information from me to get to the bottom of something. It usually takes a little longer than I would expect."
"It might be a bit much to ask, but we are now beginning to use Morphisec Scout, which provides vulnerability information. At this time, it's recognizing vulnerabilities and reporting them to us, but it's not necessarily resolving them. There's still a separate manual process to resolve those vulnerabilities, primarily through upgrades. We have to do that outside of Morphisec. If Morphisec could somehow have that capability built into it, that would be very effective."
"Sometimes it generates false positive alerts. They need to continue working on that. They have provided solutions for it and have fixed issues with updated versions. The service is quite good but they need to work on it more so that there are no false positive alerts."
"I haven't been able to get the cloud deployment to work. When there's an update, I'm supposed to be able to roll it out for the cloud solution, but right now I'm continuing to use our SCCM solution to update it."
"We have only had four attacks in the last year, "attacks" being some benign PDF from a vendor that, for some reason, were triggered. There were no actual attacks. They were just four false positives, or something lowly like adware. There have been false positives with both the on-premises solution and the cloud solution."
"The dashboard is the area that requires the most improvement. We have about, I would say 5,500 computers currently, and searching through all of those takes some time to filter. So as soon as you apply the filter, it takes a few seconds. It crunches, it thinks, and then it brings up the clients that match."
"We started in the Linux platform and we deployed to Linux. The licensing of that has been kind of confusing between Linux licensing and Windows licensing. The overall simplicity of licensing or offering an enterprise license to just cover everything and then we don't have to count needs improvement."
 

Pricing and Cost Advice

"Cortex XDR by Palo Alto Networks is an expensive solution."
"If one wishes to work with another team or large number of users at a future point, he must purchase a license for them."
"I feel it is fairly priced."
"The solution is expensive. It's pricing is on a yearly-basis."
"It's way too expensive, but security is expensive. You pay for your licensing, and then you pay for someone to monitor the stuff."
"The pricing is a little high. It is per user per year."
"I am using the Community edition."
"The return on investment is from the user side because we have seen the performance of it increase the delivery time of the product if we are using too many web-based and on-premise applications. In indirect ways, we saw the return of investment in terms of performance and user satisfaction increase."
"Kaspersky is one of the cheaper solutions."
"Kaspersky Anti-Targeted Attack Platform is cheap."
"The solution has competitive pricing."
"Morphisec is reasonably priced because our parent company's other subsidiaries use different products like CrowdStrike. CrowdStrike is four or five times more expensive than Morphisec. The competitive pricing saves us money in our overall security stack."
"It is priced correctly for what it does. They end up doing a good deal of discounting, but I think it is priced appropriately."
"It does not have multi-tenants. If South Africa wants to show only the machines that they have, they need their own cloud incidence. It is not possible to have that in a single cloud incidence with multiple tenants in it, instead you need to have multiple cloud incidences. Then, if you have that, it will be more expensive. However, they are going to change that, which is good."
"Licenses are per endpoint, and that's true for the cloud version as well. The only difference is that there is a little extra charge for the cloud version."
"Price-wise, it's on the higher side. A traditional antivirus solution is cheaper, but in terms of security and manageability, its ROI is better than a traditional antivirus. I would recommend it to anybody evaluating or considering an antivirus solution. If your system gets compromised, the cost of ransom would be a lot more. This way, it saves a lot of cost."
"Our licensing is tied into our contract. Because we have a long-term contract, our pricing is a little bit lower. It is per year, so we don't get charged per endpoint, but we do have a cap. Our cap is 80 endpoints. If we were to go over 80, when we renewed our contract, which is not until three years are over. Then, they would reevaluate, and say, "Well, you have more than 80 devices active right now. This is going to be the price change." They know that we are installing and replacing computers, so the numbers will be all over the place depending on whether you archive or don't archive, which is the reason why we just have to keep up on that stuff."
"The pricing is definitely fair for what it does."
"Compared to their competitors, the price of Morphisec is not that high. You can easily deploy it on a large-scale or small-scale network."
report
Use our free recommendation engine to learn which Endpoint Detection and Response (EDR) solutions are best for your needs.
884,933 professionals have used our research since 2012.
 

Top Industries

By visitors reading reviews
Computer Software Company
9%
Manufacturing Company
9%
Financial Services Firm
9%
Comms Service Provider
7%
Computer Software Company
13%
Comms Service Provider
10%
Government
10%
Financial Services Firm
10%
Outsourcing Company
18%
Manufacturing Company
11%
Financial Services Firm
8%
Computer Software Company
8%
 

Company Size

By reviewers
Large Enterprise
Midsize Enterprise
Small Business
By reviewers
Company SizeCount
Small Business44
Midsize Enterprise20
Large Enterprise47
No data available
By reviewers
Company SizeCount
Small Business5
Midsize Enterprise8
Large Enterprise8
 

Questions from the Community

Cortex XDR by Palo Alto vs. Sentinel One
Cortex XDR by Palo Alto vs. SentinelOne SentinelOne offers very detailed specifics with regard to risks or attacks. ...
Comparing CrowdStrike Falcon to Cortex XDR (Palo Alto)
Cortex XDR by Palo Alto vs. CrowdStrike Falcon Both Cortex XDR and Crowd Strike Falcon offer cloud-based solutions th...
How is Cortex XDR compared with Microsoft Defender?
Microsoft Defender for Endpoint is a cloud-delivered endpoint security solution. The tool reduces the attack surface,...
What do you like most about Kaspersky Anti-Targeted Attack Platform?
The solution is very easy to use. Its interface is very simple, and you can build IOC's indicators. You can use your ...
What is your experience regarding pricing and costs for Kaspersky Anti-Targeted Attack Platform?
Its price is reasonable; it's neither very high nor very low, considering its capabilities.
What needs improvement with Kaspersky Anti-Targeted Attack Platform?
I think the tool is still not really good enough for integration compared to other products. If you need to integrate...
Ask a question
Earn 20 points
 

Also Known As

Cyvera, Cortex XDR, Palo Alto Networks Traps
Kaspersky Anti Targeted Attack
Morphisec, Morphisec Moving Target Defense
 

Overview

 

Sample Customers

CBI Health Group, University Honda, VakifBank
Republic of Serbia, Goods.ru, Tael, Insolar
Lenovo/Motorola, TruGreen, Covenant Health, Citizens Medical Center
Find out what your peers are saying about Kaspersky Anti-Targeted Attack Platform vs. Morphisec and other solutions. Updated: March 2026.
884,933 professionals have used our research since 2012.